ArticleCancer biology & therapy2022

Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15.

Lei Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.